Chemotherapy-free combination regimen ushers in new era for first-line treatment, with overall survival projected to exceed four years, surpassing monotherapy TKI osimertinib by more than one year RARITAN, N.J. – Johnson… Read More
Updated MARIPOSA analysis at WCLC shows combination prevents common EGFR and MET resistance, helping patients live longer Additional study results highlight strategies to reduce dermatologic reactions and simplify administration with once-monthly subcutaneous… Read More
Deputy Premier and Minister of Health Sylvia Jones launched Ontario’s Health Innovation Pathway yesterday, creating the first systematic route for medical devices, digital health products, and care delivery innovations to… Read More
Allschwil, Switzerland & Radnor, Phila – Idorsia Ltd. announces a first-of-its-kind initiative with the Stanford Hypertension Center and Duke Heart Center to launch IMPACT-HTN, a new three-phase program to transform… Read More
LAVAL, QC – Bausch Health Companies Inc. a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics market, announced that the Company’s proven Thermage technology has… Read More
